Arrowhead Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
09.09.24
/
50%
€19.41
Target price
09.09.25
-
Performance (%)
20.97%
End price
10.09.25
€23.48
Summary
This prediction ended on 10.09.25 with a price of €23.48. The prediction had a final performance of 20.97%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 13.154% | 13.154% | 182.136% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.21
20.06.24
20.06.24
-
20.06.25
20.06.25
-39.53%
21.06.25
21.06.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€42.87
08.08.24
08.08.24
-10.25%
09.08.24
09.08.24